EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Challenges of the Oxycodone Hydrochloride Shortage

Gursan Gunes Yenidogan iD, Nagihan Duran Yakar iD, Enise Alioglu iD, Salim Taner Gözükızıl iD, Aysegul Bilen iD

Reports · 17.06.2026 · 9 (2) · 189

DOI: 10.3390/reports9020189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reports, online erschienen am 17.06.2026. Verfasst von Gursan Gunes Yenidogan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain Medicine, Prof. Dr. Cemil Tascioglu City Hospital, 34384 Istanbul, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the clinical impact and treatment adaptations during the immediate-release oxycodone hydrochloride shortage.

Methods

This retrospective, observational study was conducted during the oxycodone shortage period (May 2024–March 2025) in patients with cancer pain. Pain intensity was assessed using the Numerical Rating Scale (NRS) at baseline (prior to switching, while receiving oxycodone) and at follow-up (after switching to alternative analgesics). Changes in pain intensity were evaluated using within-patient differences (ΔNRS), with clinically meaningful worsening defined as an increase of ≥2 points. Descriptive and inferential statistics were used to summarize patient characteristics and outcomes.

Results

Of 300 patients screened, 55 met inclusion criteria (mean age 65.2 ± 11.0 years; 63.6% male). Pain intensity increased significantly following treatment modification during the period of oxycodone unavailability, with mean NRS scores rising from 4.3 ± 1.7 to 5.9 ± 2.5 (p < 0.001). The mean ΔNRS was +1.56 (95% CI 0.79–2.34), with clinically meaningful worsening observed in 36 patients (65.5%). No statistically significant association was observed between substitute analgesic type and clinically meaningful worsening (p = 0.11).

Conclusions

The oxycodone shortage was associated with worsened pain control and increased need for treatment modifications in cancer patients, highlighting the importance of uninterrupted access to essential opioids.

Schlagwörter

Stichwörter der Autor:innen

cancer paindrug shortageoxycodone hydrochloridepain management

Autor:innen und Institutionen

  • Department of Pain Medicine, Prof. Dr. Cemil Tascioglu City Hospital, 34384 Istanbul, Turkey.

ORCID-Profile: Gursan Gunes Yenidogan, Nagihan Duran Yakar, Enise Alioglu, Salim Taner Gözükızıl, Aysegul Bilen

Zitieren

APA

Yenidogan, G. G., Duran Yakar, N., Alioglu, E., Gözükızıl, S. T., & Bilen, A. (2026). Challenges of the Oxycodone Hydrochloride Shortage. Reports, 9(2), 189. https://doi.org/10.3390/reports9020189

Vancouver

Yenidogan GG, Duran Yakar N, Alioglu E, Gözükızıl ST, Bilen A. Challenges of the Oxycodone Hydrochloride Shortage. Reports. 2026;9(2):189. doi:10.3390/reports9020189

BibTeX
@article{Yenidogan2026,
  author = {Yenidogan, Gursan Gunes and Duran Yakar, Nagihan and Alioglu, Enise and Gözükızıl, Salim Taner and Bilen, Aysegul},
  title = {Challenges of the Oxycodone Hydrochloride Shortage},
  journal = {Reports},
  year = {2026},
  volume = {9},
  number = {2},
  pages = {189},
  doi = {10.3390/reports9020189}
}
Kostenlos starten →